Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Ras Gene02:38

The Ras Gene

7.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

5.7K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and Safety of the "One-Week Breast Radiation Therapy" Program.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Nosocomial influenza in south-western Swiss hospitals during two seasonal epidemics: an observational study.

The Journal of hospital infection·2021
Same author

Congenital chylothorax: Current evidence-based prenatal and post-natal diagnosis and management.

Lymphology·2019
Same author

Brain lymphatic drainage system in fetus and newborn: Birth of a new era of exploration.

Lymphology·2019

Related Experiment Video

Updated: Mar 24, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.8K

LYMPHODYSPLASIA AND KRAS MUTATION: A CASE REPORT AND LITERATURE REVIEW.

G Morcaldi, T Bellini, C Rossi

    Lymphology
    |March 5, 2016
    PubMed
    Summary

    Cardio-facio-cutaneous (CFC) syndrome, a rare RAS/MAPK pathway disorder, presents with distinct facial and developmental features. This report details a unique case with KRAS mutation, highlighting chylothorax and craniosynostosis.

    More Related Videos

    Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
    04:43

    Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

    Published on: February 27, 2020

    7.4K
    A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
    10:13

    A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

    Published on: July 3, 2013

    11.7K

    Related Experiment Videos

    Last Updated: Mar 24, 2026

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
    06:51

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

    Published on: July 21, 2018

    18.8K
    Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
    04:43

    Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

    Published on: February 27, 2020

    7.4K
    A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
    10:13

    A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

    Published on: July 3, 2013

    11.7K

    Area of Science:

    • Genetics and Molecular Biology
    • Developmental Biology
    • Clinical Medicine

    Background:

    • Cardio-facio-cutaneous (CFC) syndrome is a rare genetic disorder characterized by facial dysmorphia, ectodermal and cardiac abnormalities, growth retardation, and neurodevelopmental delay.
    • CFC syndrome belongs to the RAS syndromes, resulting from mutations in genes within the RAS/MAPK signaling pathway, including BRAF, MEK1/2, HRAS, and KRAS.
    • It shares overlapping clinical features with other RASopathies like Costello syndrome and Noonan syndrome, emphasizing the complexity of genotype-phenotype correlations.

    Observation:

    • This report presents a rare case of CFC syndrome with a specific KRAS gene mutation.
    • The patient exhibited a constellation of symptoms including chylothorax, lymphedema, sinus pericranii, craniosynostosis, and seizures.
    • This represents the second documented case of CFC syndrome with this particular genetic basis in the medical literature.

    Findings:

    • The study identifies a KRAS mutation as the molecular cause of CFC syndrome in the described patient.
    • The clinical presentation highlights the diverse and severe manifestations associated with this specific genetic defect.
    • This case underscores the importance of considering molecular diagnosis in patients with overlapping RAS syndrome phenotypes.

    Implications:

    • Accurate clinical diagnosis is crucial for proper classification and management of RAS syndromes.
    • Understanding the molecular basis of CFC syndrome aids in differentiating it from other RASopathies.
    • This case contributes to the limited literature on CFC syndrome, particularly those with KRAS mutations, potentially guiding future research and clinical approaches.